Investor Presentaiton

Investor presentation First three months of 2017 Slide 105 Solid sales growth driven by the US Reported annual sales split by region Region Europe Region J&K DKK billion 120 Reported annual sales Diabetes CAGR¹ 9.4% Biopharmaceuticals North America Region China 8% 100 8% 11% 80 25% 60 80% 79% 40 79% 78% 20 78% 0 2012 2013 2014 2015 2016 2012 1 CAGR for 5-year period changing diabetes® Region AAMEO Region LATAM 6% 9% 10% 19% 53% 44% AAMEO: Africa, Asia, Middle-East and Oceania; J&K: Japan and Korea; LATAM: Latin America. 2016 novo nordisk

View entire presentation